Based on these and scATAC-seq data, a novel mechanism for KLHL42-associated transcriptional regulation was described, further elucidating the pathogenesis of CTCL and providing novel therapeutic targets for precise treatment of the disease. The gene discussed is KLHL42; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.